Should you buy DNA (DNA) stock in 2022?

In 2022, DNA's revenue was $477.71 million, an increase of 52.21% compared to the previous year's $313.84 million. Losses were -$2.10 billion, 15.0% more than in 2021. According to 4 analysts, the average rating for DNA stock is "Sell." The 12-month stock price forecast is $1.88, which is an increase of 16.77% from the latest price.

What are DNA share price targets?

Their DNA share price targets range from $1.25 to $3.00. On average, they anticipate the company's stock price to reach $2.25 in the next year. This suggests a possible upside of 33.1% from the stock's current price. View analysts price targets for DNA or view top-rated stocks among Wall Street analysts. How have DNA shares performed in 2023?

What is the price target for Ginkgo Bioworks (DNA)?

See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. DNA's current price target is $2.25. Learn why top analysts are making this stock forecast for Ginkgo Bioworks at MarketBeat.

When is Ginkgo Bioworks (DNA) presentation & Q&A?

Presentation and Q&A session scheduled for post-market on Wednesday, November 8, 2023 BOSTON , Nov. 1, 2023 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell...